Post PCI Same Day Discharge: from Convenience to Need

Same day discharge following programed PCI with no complications has been a way for health centers to reduce costs that has resulted both safe and convenient for patients. 

Alta el mismo día post angioplastia: de una comodidad a una necesidad

With the arrival of the pandemic, reduced bed capacity, uninfected patient exposure and their potential contagion, and the always pressing need to reduce hospital costs have turned same day discharge into a necessity for many centers. 

Fortunately, the evidence on safety of same day discharge had already been shown before COVID-19, and the latter has made many operators feel they needed to implement it. 

This study included 819,091 patients undergoing programed PCI in 1,716 centers. It looked at the link between same day discharge and 30-day mortality in addition to rehospitalization.  

In this series, 14% were discharged the same day, though the proportion increased at followup: it went from a mere 4.5% at the beginning to almost 30% towards the end. This percentage grew according to an increased use of the transradial approach instead of the femoral. 

Mortality at 30 days resulted identical throughout the followup period, even though the adjusted risk of rehospitalization dropped, and this effect was more significative for patients discharged the same day (p for interaction <0.001).


Read also: AHA 2020 | Rise in Early Discharge After TAVR Has the Expected Cost.


This strategy of established safety (together with the transradial approach) can be an effective tool to keep doing programed PCI procedures during the pandemic. 

Conclusion

Same day discharge after elective PCI has been on the rise since the beginning of this practice. Mortality has not been compromised and re-hospitalization has actually dropped, which confirms the safety of this strategy. 

In pandemic times, same day discharge might have some perks. 

Original Title: Trends in Use and Outcomes of Same-Day Discharge Following Elective Percutaneous Coronary Intervention.

Reference: Steven M Bradley et al. JACC Cardiovasc Interv. 2021 Aug 9;14(15):1655-1666. doi: 10.1016/j.jcin.2021.05.043.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....